• The Clorox Company recently released its first quarter fiscal 2026 earnings, reporting sales of US$1,429 million and net income of US$80 million, both down from the prior year, while maintaining its full-year earnings guidance despite forecasting net sales to decline 6% to 10% and ongoing headwinds related to the ERP transition and divestiture impacts.
• Management emphasized that successful completion of the new enterprise resource planning system has already begun to deliver operational benefits, helping offset short-term disruption and supporting future efficiency improvements.
• We’ll examine how Clorox’s operational progress following its ERP system rollout influences its investment narrative and future outlook.

These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

Clorox Investment Narrative Recap

To be a Clorox shareholder, you need confidence in the company’s ability to drive long-term efficiency gains and margin expansion as it navigates category headwinds and shifting consumer preferences. The latest earnings did not materially change the near-term catalyst of ERP-driven operational improvements, though persistent sales declines and uncertain demand remain the foremost risks weighing on the outlook.

Of the recent announcements, management’s reaffirmed guidance for fiscal 2026 stands out, with net sales projected to decline 6% to 10% despite the successful ERP rollout. This signals that, while ERP benefits are beginning to surface, top-line growth challenges and the pace of category recovery are still key issues for the business.

Yet, investors should be aware that despite visible ERP progress, Clorox’s exposure to ongoing price competition and sluggish consumer categories means ...

Clorox is projected to reach $7.0 billion in revenue and $881.8 million in earnings by 2028. This outlook assumes a 0.4% annual decline in revenue and a $71.8 million increase in earnings from the current $810.0 million.

Uncover how Clorox's forecasts yield a $124.76 fair value, a 20% upside to its current price.

Exploring Other Perspectives

Six Simply Wall St Community members’ fair value estimates for Clorox range widely between US$98.22 and US$213.56. While some see ERP-led efficiency as a catalyst for future margin improvement, persistent sales pressures invite a closer look at how expectations can sharply diverge across the market.

Explore 6 other fair value estimates on Clorox - why the stock might be worth over 2x more than the current price!

Build Your Own Clorox Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Clorox research is our analysis highlighting 5 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Clorox research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Clorox's overall financial health at a glance.

Seeking Other Investments?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Outshine the giants: these 25 early-stage AI stocks could fund your retirement.
• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• The latest GPUs need a type of rare earth metal called Neodymium and there are only 36 companies in the world exploring or producing it. Find the list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.